Reducing Disparities in Lung Cancer Screening: It’s Not so Black and White
Menée aux Etats-Unis à partir d'une version de travail des recommandations 2020 de l'"United States Preventive Services Task Force" concernant le dépistage des cancers du poumon, cette étude estime le bénéfice de ces recommandations en matière de réduction des inégalités ethniques par rapport aux recommandations 2013 et évalue l'intérêt d'un modèle prédictif pour identifier parmi les personnes inéligibles au dépistage celles qui devraient l'être
Lung cancer is the leading cause of cancer death in the United States. This is true for Black, Asian, White men and women as well as Hispanic men. To reduce lung cancer death lung cancer screening with low-dose computed tomography (LDCT) was recommended by the US Preventative Task Force (USPSTF) in 2013 for high risk individuals. These recommendations were based on the National Lung Cancer Screening Trial that showed a 20% relative reduction in lung cancer death among participants. This marked the first-time cancer screening was only recommended for a high-risk group. Researchers then began to question if these simple criteria adequality selected patients, especially given that Black populations smoke fewer cigarettes, are diagnosed at a younger age, and have a higher risk of developing and dying from lung cancer. In July 2020, the USPSTF issued draft recommendations expanding the pool of eligible candidates by lowering the age at which to begin screening and pack-year thresholds. One of their goals was to reduce disparities and to include more racial/ethnic minorities, specifically Black individuals.
Journal of the National Cancer Institute , éditorial en libre accès, 2020